Addition of low dose of metformin to the oral contraceptive has no great advantage in terms of cardiovascular risk markers in women with polycystic ovary syndrome regardless insulin resistance (2010)
- Authors:
- USP affiliated authors: FERRIANI, RUI ALBERTO - FMRP ; SÁ, MARCOS FELIPE SILVA DE - FMRP
- Unidade: FMRP
- Subjects: DISPOSITIVOS ANTICONCEPCIONAIS; SÍNDROME DO OVÁRIO POLICÍSTICO; SISTEMA CARDIOVASCULAR
- Language: Inglês
- Imprenta:
- Publisher place: Philadelphia
- Date published: 2010
- Source:
- Título do periódico: Fertility and Sterility
- ISSN: 0015-0282
- Volume/Número/Paginação/Ano: v. 94, n. 4 suppl, p. S63-S64, res. O-217, 2010
- Conference titles: Annual Meeting of the American Society (ASRM)
-
ABNT
VIEIRA, C. S. et al. Addition of low dose of metformin to the oral contraceptive has no great advantage in terms of cardiovascular risk markers in women with polycystic ovary syndrome regardless insulin resistance. Fertility and Sterility. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 18 abr. 2024. , 2010 -
APA
Vieira, C. S., Fernandes, J. B. F., Soares, G. M., Martins, W. de P., Sá, M. F. S. de, & Ferriani, R. A. (2010). Addition of low dose of metformin to the oral contraceptive has no great advantage in terms of cardiovascular risk markers in women with polycystic ovary syndrome regardless insulin resistance. Fertility and Sterility. Philadelphia: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. -
NLM
Vieira CS, Fernandes JBF, Soares GM, Martins W de P, Sá MFS de, Ferriani RA. Addition of low dose of metformin to the oral contraceptive has no great advantage in terms of cardiovascular risk markers in women with polycystic ovary syndrome regardless insulin resistance. Fertility and Sterility. 2010 ; 94( 4 suppl): S63-S64.[citado 2024 abr. 18 ] -
Vancouver
Vieira CS, Fernandes JBF, Soares GM, Martins W de P, Sá MFS de, Ferriani RA. Addition of low dose of metformin to the oral contraceptive has no great advantage in terms of cardiovascular risk markers in women with polycystic ovary syndrome regardless insulin resistance. Fertility and Sterility. 2010 ; 94( 4 suppl): S63-S64.[citado 2024 abr. 18 ] - Sindrome dos ovarios policisticos e hiperprolactinemia. Uma base fisiopatologica comum?
- Agenesia da vagina: correcao cirurgica pela tecnica de mcindoe
- Funcao tireoideana e gravidez
- Hipotalamic amenorrhea - action of dopamine on gonadotropin secretion
- Avaliação dos níveis de leptina de variáveis antropométricas em mulheres climatéricas usuárias de raloxifeno
- Meiotic spindle evaluation of bovine oocytes submitted to in vitro maturation after pretreatment with butyrolactone I, an inhibitor of premature meiotic resumption
- Aromatization maintenance during granulosa-luteinic cells culture may provide a good co-culture system for in vitro maturation procedures
- Vascular function impaired found in obese young women with the polycystic ovary syndrome
- Variations of jitter and shimmer among women in menacme and postmenopausal women
- Anovulacao cronica
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
